TransCode Therapeutics, Inc. (RNAZ)
$1.63-12.37%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 1.26
- P/E (TTM)
- -0.04
- Short % float
- 6.01%
- Days to cover
- 1.0
- SI change
- -15.2%
- 1W
- -7.39%
- 1M
- -3.55%
- vs SPY 1W
- -7.81%
- vs SPY 1M
- -5.61%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on RNAZ?
- LOPJLB’s latest quantitative signal on TransCode Therapeutics, Inc. (RNAZ) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RNAZ in?
- TransCode Therapeutics, Inc. (RNAZ) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does TransCode Therapeutics, Inc. (RNAZ) do?
- TransCode Therapeutics, Inc. is a biopharmaceutical firm dedicated to pioneering and marketing therapeutic agents and diagnostic tools specifically aimed at combating and detecting metastatic disease. Central to its pipeline is TTX-MC138, a lead therapeutic compound currently undergoing preclinical evaluation for its potential in treating advanced, spreading cancers. Beyond its primary candidat…